Given the significant presence of CAFs in PDAC, intensive uptake of Gallium-68 FAP inhibitor (Ga68-FAPI) is expected, as demonstrated in previous studies showing a promising clinical value of Ga68-FAPI PET/CT for pancreatic cancer diagnosis [20,21]. This evidence concerns the gene FAP and familial pancreatic carcinoma.